SCHEMBL24106938

SCHEMBL24106938

c1ccc(-c2ccccc2-c2c3ccccc3c(-c3ccc4c(c3)oc3ccccc34)c3cc(-c4ccc5c(-c6ccccc6)c6ccccc6c(-c6ccc7c(c6)oc6ccccc67)c5c4)ccc23)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 2/20 0.41
MEN1 O00255 3/20 0.40
MAPT P10636 3/20 0.40
KMT2A Q03164 3/20 0.40
HPGD P15428 3/20 0.40
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 2/20 0.40
MMP12 P39900 1/20 0.39
MMP13 P45452 1/20 0.39
PLA2G2A P14555 4/20 0.39
PLA2G4A P47712 4/20 0.39
HCRTR1 O43613 1/20 0.38
PLA2G10 O15496 1/20 0.37
CA1 P00915 3/20 0.36
CA2 P00918 3/20 0.36
NTRK1 P04629 1/20 0.36
PLK3 Q9H4B4 1/20 0.36
ALOX5 P09917 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
NPC1 O15118 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21020579 1.00 AHR (0.41) AHRMEN1MAPTKMT2AHPGD
SCHEMBL22987256 0.95 PLA2G2A (0.43) AHRMEN1MAPTKMT2AHPGD
SCHEMBL24982971 0.94 MMP12 (0.43) AHRMEN1MAPTKMT2AHPGD
SCHEMBL20650659 0.94 AHR (0.45) AHRMEN1MAPTKMT2AHPGD
SCHEMBL25102758 0.94 PLA2G2A (0.41) AHRMEN1MAPTKMT2AHPGD
SCHEMBL22854993 0.93 PLA2G2A (0.44) AHRMEN1MAPTKMT2AHPGD
SCHEMBL21763711 0.93 AHR (0.41) AHRMEN1MAPTKMT2AHPGD
SCHEMBL24285561 0.93 AHR (0.44) AHRMEN1MAPTKMT2AHPGD
SCHEMBL25624663 0.92 PLA2G2A (0.45) AHRMEN1MAPTKMT2AHPGD
SCHEMBL25624664 0.92 PLA2G2A (0.45) AHRMEN1MAPTKMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11780856-B2 Compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2023-10-10 US disclosed
US-20230002420-A1 ORGANIC LIGHT-EMITTING ELEMENT LG CHEM, LTD. (KR) 2023-01-05 US disclosed
US-20210391547-A1 BORON-CONTAINING COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2021-12-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230002420-A1 ORGANIC LIGHT-EMITTING ELEMENT CYBA, CRY1, CYP1A1 AHR 10/4885MEN1 1394/4885MAPT 2485/4885
US-11780856-B2 Compound and organic light-emitting device comprising same CRY1, CRY2, LEF1 AHR 521/4885MEN1 449/4885MAPT 595/4885
US-20210391547-A1 BORON-CONTAINING COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME CRY1, POU2F1, LEF1 AHR 601/4885MEN1 566/4885MAPT 854/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.